top of page

Home
Pipeline
Science
News
More

Use tab to navigate through the menu items.

Acerca de

Nurse Talking to Patient

Pipeline
Harnessing Immune Regulation to Treat Serious Inflammatory Diseases

Azora Pipeline Dec 2023.png

AT177 and AT193 aare for investigational use only and have not been approved by the FDA or any other regulatory agency for commercial use. The safety and efficacy of these products have not been established for use.

Copyright © 2023 by Azora Therapeutics Inc and Azora Therapeutics Australia Pty Ltd. All Rights Reserved.

bottom of page